Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,307,600 | 3,666,400 | 3,238,800 | 3,315,500 | 3,064,800 |
| Marketable Securities | 687,400 | 785,400 | 1,080,400 | 915,400 | 1,075,000 |
| Receivables | 4,187,400 | 4,071,600 | 4,067,700 | 4,096,600 | 3,825,700 |
| Inventories | 3,740,200 | 3,445,800 | 3,417,700 | 3,288,400 | 2,980,200 |
| TOTAL | $11,714,600 | $12,573,600 | $12,567,000 | $12,346,000 | $11,742,700 |
| Non-Current Assets | |||||
| PPE Net | 8,033,100 | 8,053,500 | 8,075,300 | 8,022,600 | 7,950,700 |
| Investments And Advances | 3,764,300 | 3,646,600 | 4,102,000 | 4,099,100 | 4,576,500 |
| Intangibles | 4,889,800 | 5,034,800 | 4,615,900 | 4,842,900 | 4,947,700 |
| Other Non-Current Assets | 6,290,000 | 6,260,400 | 6,944,500 | 6,726,000 | 6,436,300 |
| TOTAL | $22,977,200 | $22,995,300 | $23,737,700 | $23,690,600 | $23,911,200 |
| Total Assets | $34,691,800 | $35,568,900 | $36,304,700 | $36,036,600 | $35,653,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 10,800 | 805,400 |
| Accounts payable and accrued liabilities | 1,151,600 | 1,338,200 | 1,179,300 | 1,153,000 | 1,179,600 |
| Other current liabilities | 5,426,400 | 5,987,400 | 5,471,100 | 5,626,200 | 5,061,200 |
| TOTAL | $7,340,900 | $8,229,600 | $8,303,300 | $8,232,000 | $8,342,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,477,600 | 7,972,400 | 8,069,600 | 7,988,600 | 7,415,300 |
| Other Non-Current Liabilities | 4,843,900 | 4,776,600 | 4,690,900 | 5,110,600 | 4,949,200 |
| TOTAL | $12,321,500 | $12,749,000 | $12,760,500 | $13,099,200 | $12,364,500 |
| Total Liabilities | $19,662,400 | $20,978,600 | $21,063,800 | $21,331,200 | $20,707,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,103,837 | 1,106,093 | 1,108,077 | 1,108,541 | 1,109,741 |
| Common Shares | 690,300 | 691,300 | 693,000 | 693,300 | 694,100 |
| Retained earnings | 16,155,000 | 16,011,800 | 16,856,700 | 16,114,900 | 16,706,800 |
| Other shareholders' equity | -7,257,900 | -7,574,900 | -7,660,700 | -7,381,300 | -7,644,000 |
| TOTAL | $15,029,400 | $14,590,300 | $15,240,900 | $14,705,400 | $14,946,500 |
| Total Liabilities And Equity | $34,691,800 | $35,568,900 | $36,304,700 | $36,036,600 | $35,653,900 |